FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

phase I News

Most Popular phase I Story

Researchers target multiple tumors in new cancer vaccine study

Targeting a variety of tumor types, the Roswell Park Cancer Institute has begun recruiting patients for an early-stage clinical trial to test an experimental cancer vaccine. The vaccine, or Read more...

phase I Press Releases

  • Plexxikon Announces Encouraging Data from Phase 1 Extension Study of PLX4032 Showing Objective Responses
  • Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
  • VaxInnate's Universal Flu Vaccine Candidate Shown Safe and Immunogenic in Phase I Clinical Study
  • Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
  • Emergent BioSolutions Announces Commencement of Phase I/II Trial of Anthrax Immune Globulin for Treating Anthrax Disease

Latest Headlines